Awards
Paul Ehrlich Lectureship Award: Amy D. Klion, MDThe Paul Ehrlich Lectureship Award is the most prestigious recognition given by the International Eosinophil Society. It honors an individual who has made exceptional, prolific, and high-quality research contributions that have significantly advanced our understanding of the molecular mechanisms of eosinophils in both health and disease. Dr. Klion will give the prestigious Paul Ehrlich Lecture on Tuesday, 13 July 2027 at 4:00 pm.
|
Eosinophilic Disease Translational Research Award: Florence Roufosse, MD, PhDThe Eosinophilic Disease Translational Research Award recognizes a scientist whose translational research has helped lead to substantial improvement in the understanding, diagnosis and care of patients afflicted by eosinophilic disease. Patient-oriented translational research is a critical component towards improving outcomes in the era of personalized medicine, both for individual patients and for the community-at-large. Dr. Roufosse will give a special lecture on Wednesday, 14 July 2027 at 11:00 am and accept her award during the Awards Dinner.
|
Distinguished Service to the Eosinophil Research Community Award: Michael Minnicozzi, PhDThe Distinguished Service to the Eosinophil Research Community Award recognizes an individual whose outstanding contributions and longstanding service have had a meaningful and lasting impact on the eosinophil research community. This special, one-time award honors the recipient’s dedication to advancing eosinophil research and supporting the continued growth of the field. Dr. Minnicozzi will accept the award during the Awards Dinner on Thursday, 15 July 2027.
|
Dr. Amy D. Klion, MD is a Senior Investigator, head of the Human Eosinophil Section and Deputy Chief of the Laboratory of Parasitic Diseases at the NIH. Her research program includes basic and translational research related to the role of the eosinophil and eosinophil activation in disease pathogenesis. The ultimate goal of her laboratory is to develop novel diagnostic tools and treatment approaches for hypereosinophilic syndromes and other conditions associated with marked eosinophilia, including helminth infection. Dr. Klion has been an active member of the IES since 2001 and has contributed to the Society in numerous leadership roles, including serving as IES President from 2011–2013. She is a Fellow of the American Society of Tropical Medicine and Hygiene and a recipient of the Society’s Bailey K. Ashford Medal. Dr. Klion has served on the editorial boards of Blood and the Journal of Allergy and Clinical Immunology and numerous advisory committees and expert panels related to her work on eosinophilic disorders and neglected tropical diseases. She is the author of more than 250 scholarly articles, reviews, and textbook chapters. 
Dr. Florence Roufosse is Professor of Medicine, Internist and Clinical Immunologist at CUB- Hôpital Erasme, Brussels, and is the Past President of the International Eosinophil Society. She is in charge of a specialized consultation dedicated to diagnosing and treating eosinophil-related conditions, that is integrated in the European Reference Network: EuroBloodNet. She also manages patients with systemic auto-immune and auto-inflammatory conditions. Besides these clinical activities, Dr. Roufosse leads translational research projects to improve understanding and treatment of lymphocytic variant hypereosinophilic syndrome (HES), and participates in international research efforts to better delineate disease course and treatment responses of HES. She is involved in the design and conduct of international clinical trials evaluating efficacy of novel treatment options in patients with HES and eosinophilic granulomatosis with polyangiitis (EGPA), as well as sub-studies that aim to identify biomarkers and/or disease variants predicting treatment responses.
Dr. Michael Minnicozzi joined the NIAID’s Division of Allergy, Inflammation and Transplantation in October 2005 as a Program Officer. He received his doctoral degree in physiology from the University of Medicine and Dentistry of New Jersey. Prior to joining the Division, he was a Principal Research Scientist at the Schering Plough Research Institute in Kenilworth NJ. Mike has over 25 years of preclinical and clinical pharmaceutical research experience and several years of experience in business development. His scientific interests cover; pulmonary inflammation and physiology, eosinophil and epithelial cell biology, animal models of human disease and pharmacology. During his employment at SPRI, Dr. Minnicozzi also served on the Northeast Peer Review Consortium of the American Heart Association and was an Adjunct Professor at UMDNJ. In addition to his programmatic oversight of grant and contract portfolios for the NIAID, Mike also provides programmatic and scientific stewardship for the entire NIAID-DAIT portfolio of Small Business awards.